Residential Retreat for Veterans and First-responders

PTSD Clinical Trial

Official title:

Examining the Efficacy and Feasibility of a Residential Retreat Program for PTSD in First-responders and Veterans: A Non-randomized Controlled Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05311696
• Other study ID #: 2650
• Status: Recruiting
• Start date: March 27, 2022
• Est. completion date: November 21, 2023

Study information

• Verified date: March 2022
• Source: Valhalla Project Niagara
• Contact: Pouria Saffaran, Bsc
• Phone: 647-895-7474
• Email: pouria.saffaran[@]alum.utoronto.ca
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to determine the potential efficacy and feasibility of a residential retreat program to address PTSD symptoms in Veterans and First-responders

Description:

After obtaining written consent, participants will complete their program as they had previously intended. Each wave of the residential retreat program will last 5 days. During the program, participants will complete the study questionnaires. They will complete these questionnaires again 1 month after the completion of the program. As a control, individuals completing the program in the online format will also be asked to provide written consent and will complete the questionnaires during the program and 1-month after its completion.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 70
• Est. completion date: November 21, 2023
• Est. primary completion date: November 21, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Diagnosis of PTSD, being a military veteran or first-responder, awareness of treating physician about program attendance

Exclusion Criteria:

• None

Related Conditions & MeSH terms

• PTSD

Intervention

Other:
• psychoeducation
The program consists of psychoeducational material regarding PTSD, demonstration of various stress management techniques, and social cohesion activities

Locations

Country	Name	City	State
Canada	Valhalla Project Niagara	Niagara-on-the-lake	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
Valhalla Project Niagara

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Symptom Management of PTSD Using the Perceived Medical Condition Self-Management Scale	determining the potential efficacy of the residential program for improving symptom management. The scale is adapted to reflect participants management of their PTSD symptoms. Score ranges from 8 to 40. Higher scores indicate better management.	1-month after completion of the program
Primary	Drop-out rate in the Residential Program	Determining the extent of treatment drop-out in the Residential Program	at the end of the 5-day residential program for the residential cohort
Primary	Symptoms of PTSD Indicated by the PTSD Checklist for DSM-5 scale.	determining the potential efficacy of the residential program for improving PTSD symptoms. Scores range from 0 to 80. Higher scores indicate more symptoms of PTSD.	1-month after completion of the program
Primary	Interpersonal and Intrapersonal Functioning Using the Brief Inventory of Psychosocial Functioning (B-IPF)	determining the potential efficacy of the residential program for improving interpersonal and intrapersonal functioning (e.g., relationship with family, ability to manage daily tasks, etc.). Scores range from 0 to 42. Higher scores indicate more problems and lower functioning.	1-month after the completion of the program
Primary	Drop-out rate in the Online Program	Determining the extent of treatment drop-out in the Online Program	at the end of the 2 month online program for the online cohort.